Cargando…
Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency
BACKGROUND: Bronchoscopic lung volume reduction using one-way endobronchial valves (EBVs) is a valid therapy for severe emphysema patients. However, alpha-1 antitrypsin (AAT)-deficient patients were excluded from the majority of clinical trials investigating this intervention. OBJECTIVES: The aim of...
Autores principales: | Everaerts, Stephanie, Hartman, Jorine E., Van Dijk, Marlies, Koster, T. David, Slebos, Dirk-Jan, Klooster, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932842/ https://www.ncbi.nlm.nih.gov/pubmed/36549279 http://dx.doi.org/10.1159/000528182 |
Ejemplares similares
-
Prevalence and Impact of COVID-19 among Severe COPD Patients post Bronchoscopic Lung Volume Reduction Treatment with Endobronchial Valves
por: Klooster, Karin, et al.
Publicado: (2022) -
Comparison of Multiple Diagnostic Tests to Measure Dynamic Hyperinflation in Patients with Severe Emphysema Treated with Endobronchial Coils
por: van Dijk, Marlies, et al.
Publicado: (2021) -
Change in Dynamic Hyperinflation After Bronchoscopic Lung Volume Reduction in Patients with Emphysema
por: van Dijk, Marlies, et al.
Publicado: (2020) -
Long-term follow-up after bronchoscopic lung volume reduction valve treatment for emphysema
por: Hartman, Jorine E., et al.
Publicado: (2022) -
Safety and Considerations of the Anaesthetic Management during Bronchoscopic Lung Volume Reduction Treatments
por: Roodenburg, Sharyn A., et al.
Publicado: (2023)